Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

Phone: 212-426-7040
FallingKnifeJuggler
FallingKnifeJuggler Dec. 3 at 8:04 PM
$ARKG what money laundering scheme is driving this up today?
1 · Reply
JFDI
JFDI Dec. 3 at 7:28 PM
0 · Reply
Markus01
Markus01 Dec. 3 at 5:08 AM
$ARKG ARK Genomic Revolution - Multi-Year Breakout Price Targets: $32.92, $35.51 The breakout is just starting as you can see from the descending wedge starting in 2022. The targets are set at the 50% retrace level and the 618 fib level. The chart shows these are strong areas of support/resistance. Golden Ratio Target = $57.42
0 · Reply
Benpsf
Benpsf Dec. 3 at 4:57 AM
$ARKG ARK Genomic Revolution - Multi-Year Breakout Price Targets: $32.92, $35.51 The breakout is just starting as you can see from the descending wedge starting in 2022. The targets are set at the 50% retrace level and the 618 fib level. The chart shows these are strong areas of support/resistance. Golden Ratio Target = $57.42
0 · Reply
mankind1
mankind1 Dec. 3 at 2:10 AM
$ARKG second best etf out there.
0 · Reply
jaydilks
jaydilks Dec. 2 at 9:19 PM
$ARKG Added more at the close. Starting to become a large position.
0 · Reply
Stockwhisperr
Stockwhisperr Nov. 30 at 3:54 PM
$BFLY A few more weeks of consolidation will setup the next move higher in tandem with the $IWM. Butterfly will make big strides in 2026! What’s coming for $BFLY will leave many speechless and others in disbelief. Many bag holders will soon be free of their misery. - Octiv - Butterfly Garden - Home Healthcare Partnership with Optum - P5 Apollo - Compass - Cart Based Systems - EU Lead Exemption Determination - Announcment of Top 5 Hospital Enterprise Deal - Development of X Chip - Chip Licensing Deals Lead to ZERO Cash Burn - Very Soon Will Have Breakeven Quarter $BFLY Will be one of the biggest long term ROI for $ARKG. When $BFLY reaches breakeven and profitability the stock will make massive moves and most will still be non believers. Few Understand 🦋
0 · Reply
trendtrader6
trendtrader6 Nov. 29 at 4:25 PM
$ARKG strong week for genomics.
0 · Reply
Benpsf
Benpsf Nov. 28 at 4:20 PM
$ARKG ARK Genomic Revolution - Multi-Year Breakout Price Targets: $32.92, $35.51, $43.88 Breakout was retested and price is moving higher off the volume shelf and trendline. The move looks to be just starting, with an eventual retrace to $43.88. First targets are set at $32.92 and $35.51 at the 50% retrace level and 618 fib level.
0 · Reply
tradingmindsetannddata
tradingmindsetannddata Nov. 28 at 4:14 PM
$ARKG ARK Genomic Revolution - Multi-Year Breakout
0 · Reply
Latest News on ARKG
ARKG: I'm Holding Off Buying For These 3 Reasons

Aug 28, 2025, 8:25 AM EDT - 3 months ago

ARKG: I'm Holding Off Buying For These 3 Reasons


ARKG: April's Wash-Out Low Is Encouraging, Healthcare Still Soft

Jul 25, 2025, 9:43 AM EDT - 4 months ago

ARKG: April's Wash-Out Low Is Encouraging, Healthcare Still Soft


Best Healthcare ETFs To Buy Now

Oct 31, 2024, 2:03 PM EDT - 1 year ago

Best Healthcare ETFs To Buy Now

FXH IXJ VHT XBI XLV


Interest Rate Regimes And ARKG: Underperformance Explained

Oct 8, 2024, 8:00 AM EDT - 1 year ago

Interest Rate Regimes And ARKG: Underperformance Explained


ARKG: A Genomics Play But Active Isn't Adding Value

Jun 24, 2024, 1:07 AM EDT - 1 year ago

ARKG: A Genomics Play But Active Isn't Adding Value


Analyzing ARKG's Trading Activity In Q3

Nov 22, 2023, 11:31 PM EST - 2 years ago

Analyzing ARKG's Trading Activity In Q3


How to Find the Best Biotech ETFs

Oct 30, 2023, 4:52 PM EDT - 2 years ago

How to Find the Best Biotech ETFs

IBB XBI


ARKG ETF: An Enticing Play, But Risks Galore

Sep 28, 2023, 11:15 AM EDT - 2 years ago

ARKG ETF: An Enticing Play, But Risks Galore


3 Top Growth ETFs to Buy Right Now

Aug 14, 2023, 8:45 AM EDT - 2 years ago

3 Top Growth ETFs to Buy Right Now

EEM


Cathie Wood Says ARK Funds Are Seeing Flows Coming Back

Jul 17, 2023, 4:57 PM EDT - 2 years ago

Cathie Wood Says ARK Funds Are Seeing Flows Coming Back

ARKF ARKK ARKW


Investing in Biotech ETFs

May 23, 2023, 4:39 PM EDT - 2 years ago

Investing in Biotech ETFs

ACAD AGIO AMGN BBH BMRN CDNA EXAS


FallingKnifeJuggler
FallingKnifeJuggler Dec. 3 at 8:04 PM
$ARKG what money laundering scheme is driving this up today?
1 · Reply
JFDI
JFDI Dec. 3 at 7:28 PM
0 · Reply
Markus01
Markus01 Dec. 3 at 5:08 AM
$ARKG ARK Genomic Revolution - Multi-Year Breakout Price Targets: $32.92, $35.51 The breakout is just starting as you can see from the descending wedge starting in 2022. The targets are set at the 50% retrace level and the 618 fib level. The chart shows these are strong areas of support/resistance. Golden Ratio Target = $57.42
0 · Reply
Benpsf
Benpsf Dec. 3 at 4:57 AM
$ARKG ARK Genomic Revolution - Multi-Year Breakout Price Targets: $32.92, $35.51 The breakout is just starting as you can see from the descending wedge starting in 2022. The targets are set at the 50% retrace level and the 618 fib level. The chart shows these are strong areas of support/resistance. Golden Ratio Target = $57.42
0 · Reply
mankind1
mankind1 Dec. 3 at 2:10 AM
$ARKG second best etf out there.
0 · Reply
jaydilks
jaydilks Dec. 2 at 9:19 PM
$ARKG Added more at the close. Starting to become a large position.
0 · Reply
Stockwhisperr
Stockwhisperr Nov. 30 at 3:54 PM
$BFLY A few more weeks of consolidation will setup the next move higher in tandem with the $IWM. Butterfly will make big strides in 2026! What’s coming for $BFLY will leave many speechless and others in disbelief. Many bag holders will soon be free of their misery. - Octiv - Butterfly Garden - Home Healthcare Partnership with Optum - P5 Apollo - Compass - Cart Based Systems - EU Lead Exemption Determination - Announcment of Top 5 Hospital Enterprise Deal - Development of X Chip - Chip Licensing Deals Lead to ZERO Cash Burn - Very Soon Will Have Breakeven Quarter $BFLY Will be one of the biggest long term ROI for $ARKG. When $BFLY reaches breakeven and profitability the stock will make massive moves and most will still be non believers. Few Understand 🦋
0 · Reply
trendtrader6
trendtrader6 Nov. 29 at 4:25 PM
$ARKG strong week for genomics.
0 · Reply
Benpsf
Benpsf Nov. 28 at 4:20 PM
$ARKG ARK Genomic Revolution - Multi-Year Breakout Price Targets: $32.92, $35.51, $43.88 Breakout was retested and price is moving higher off the volume shelf and trendline. The move looks to be just starting, with an eventual retrace to $43.88. First targets are set at $32.92 and $35.51 at the 50% retrace level and 618 fib level.
0 · Reply
tradingmindsetannddata
tradingmindsetannddata Nov. 28 at 4:14 PM
$ARKG ARK Genomic Revolution - Multi-Year Breakout
0 · Reply
jaydilks
jaydilks Nov. 26 at 3:31 PM
$ARKG Nice day to add if you think you missed the boat. The exciting thing is that 70 and 80 RSIs are about to expand much higher over the next two weeks or so. Ceiling likely expands to $50+ going into 2026. Great Setup and recovery happening.
0 · Reply
Markus01
Markus01 Nov. 25 at 6:25 PM
$ARKG ARK Genomic Revolution - Multi-Year Breakout Price Targets: $32.92, $35.51 ARKG retested the breakout area and is now moving higher off the volume shelf. The next targets are $32.92 at the 50% retracement level. After that is $35.51 at the 618 fib level. Golden Ratio Target = $57.42
0 · Reply
neverdiejs
neverdiejs Nov. 24 at 9:52 PM
https://www.youtube.com/watch?v=Nkwi8I_BaWs Trading Trends 11/24/25 $QQQ Rallies 2.7% while Volatility & Staples Fall By John Salama Top Standard Deviation (Surprise) Moves of the Day Sorted by Multiple Sigma Move Gainers: +2.5% QQQI (Neos Nasdaq 100 High Income ETF) Losers: -7.1% $VXX (Ipath.B S&P 500 VIX Short-Term Futures ETN) -1.2% XLP (S&P 500 Cons Staples Sector SPDR) Top 3 Gainers of the Past 5 Days: +12.5% ARKG (Ark Genomic Revolution ETF) +5.5% KRE (S&P Regional Banking ETF SPDR) +4.4% ITB (US Home Construction Ishares ETF) Top 3 Losers of the Past 5 Days: -4.1% VXX (Ipath.B S&P 500 VIX Short-Term Futures ETN) -3.2% IBIT (Ishares Bitcoin Trust ETF) -3.2% EWY (South Korea Ishares MSCI ETF) Top 3 Trades of the Past 5 Days: LONG $ARKG LONG $KRE LONG $ITB
0 · Reply
BootySqueeze
BootySqueeze Nov. 22 at 9:07 PM
$CRSP https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/how-the-first-crispr-based-therapy-approval-impacts-crispr-t/amp $TEM $ARKG
0 · Reply
trendtrader6
trendtrader6 Nov. 22 at 7:58 PM
$ARKG daily
0 · Reply
trendtrader6
trendtrader6 Nov. 22 at 7:57 PM
$ARKG weekly. ARKK genomics setting up nicely for 2026
0 · Reply
Nick_Drendel
Nick_Drendel Nov. 22 at 5:48 PM
$ARKG - Genomics ETF: Healthcare/Biotech are dominating the market right now, so anything healthcare adjacent themes that are showing relative strength go to the top of my focus. Could play out my favorite setup out of a correction, HL50Pop setup. Rally to the 50SMA, fail, pullback for a lower high, compress to build pivot, then break through slightly below the 50SMA. https://join.marketpulsetrader.com/NDST
0 · Reply
jaydilks
jaydilks Nov. 22 at 12:26 PM
$ARKG Eli Lilly became a Trillion Dollar Company this week. Even though it’s not in ARKG, it will give investors new confidence to find the next Trillion Dollor Company for 2036 that might be edgy and become acquired by an older “Big Pharma. Lots of pieces to be acquired that are desirable in ARKG. The whole list !
0 · Reply
JFDI
JFDI Nov. 21 at 8:38 PM
0 · Reply
Teslamjp
Teslamjp Nov. 21 at 7:37 PM
$ARKG let’s gooo!
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Nov. 21 at 4:40 PM
$ARKG 👀
1 · Reply
BarbaraLyons
BarbaraLyons Nov. 20 at 8:37 PM
0 · Reply